We endeavor to disclose prompt, fair and accurate information to all shareholders/investors.
We undertake timely and proper information disclosure on the basis of transparency, fairness and continuity in accordance with applicable laws and ordinances such as the Financial Instruments and Exchange Act and the “Timely Disclosure Rules for Company Information” established by Tokyo Stock Exchange. It is our policy to disclose actively and fairly information that is not included in the laws and ordinances and/or the Timely Disclosure Rules for Company Information if such information is judged to help shareholders/investors have a better understanding of the Company.
Information disclosure methods
Disclosure of critical information that falls under the Timely Disclosure Rules for Company Information defined by Tokyo Stock Exchange is registered on the TSE timely disclosure transmission system (TDnet) for disclosure after preliminary explanation provided to TSE. The information disclosed on TDnet will also be posted promptly on our home page.We will also widely disclose information that is not applicable to the Timely Disclosure Rules for Company Information by posting such information on our home page.
Of our disclosed information, the information other than past or current facts is the future outlook as judged by the Company based on the currently available information and it should therefore be noted that actual performances, etc. may greatly differ from the disclosed information depending on various risks including the economic situation and uncertain factors.
IR quiet period
We have an IR quiet period during which the Company will not answer questions or comment on the current financial quarter or future financial projections and/or results.
The Company’s IR quiet period starts from the day following the end of a (quarterly) accounting period to the date of announcement of the financial results.
In the event that future financial results are expected to be materially different or a critical fact occurs during this period, we will promptly disclose such information. We will also answer questions about the information the Company previously disclosed as appropriate.
When using IR information
The IR information on this website is intended to provide financial information and management indices, and others, of D. Western Therapeutics Institute, Inc (hereinafter the Company). No warrant or representation is made by the Company for the contents of the website. In no way is the information contained in the website intended to solicit an investment in the Company on the part of the users. We request that investment decision be made at your discretion and not by depending solely on the information provided in the website.
While the Company makes all reasonable efforts to ensure that all information on this website is correct, accuracy cannot be guaranteed and the Company does not assume any responsibility for the correctness of any information contained in this website. The Company also cannot be held liable under any circumstances for any damages whatsoever resulting from data falsification by third parties, data download, and so forth.
The information on this website includes forward-looking statements. These forward-looking statements do not guarantee our future financial results, but involve risks and uncertainties that could cause actual results to differ materially from those discussed in the forward-looking statements.
Operation of the website
The information on this website is subject to change, and operation of the website itself is subject to discontinuation without notice at any time. The website may not be used properly depending on the communication environment, the users’ computer conditions, and other reasons. The Company does not assume any responsibility for any troubles, losses, or damages resulting from the use of this website.